Back to Search Start Over

Daratumumab Monotherapy in Previously Untreated High-Risk Patients with Stage 3B Light Chain (AL) Amyloidosis: A Phase II Multicenter Study By European Myeloma Network (EMN)

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......2127..3664ba60a709d33fa0f2651bab58b373